FGFR2 and gastric cancer: We examined the growth inhibitory effect of PD173074 (0.004–80 μM) on four FGFR2-amplified (HSC-43, TU-KATPIII, SNU-16 and HSC-39) and four non-amplified (44As3, 58As1, IM95 and OCUM1) gastric cancer cell lines.